LAVA Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $4,990 |
Gross Profit | -8 | -107 | -19,560 | |
EBITDA | -7,179 | -8,559 | -3,018 | -3,109 |
EBIT | -7,182 | -8,567 | -3,125 | -3,196 |
Net Income | -7,188 | -8,639 | -3,479 | -3,970 |
Net Change In Cash | 0 | 0 | 0 | 4,990 |
Free Cash Flow | -4,868 | -13,749 | -11,645 | -1,405 |
Cash | 49,664 | 26,380 | 39,674 | 35,015 |
Basic Shares | 26,899 | 26,899 | 26,892 | 26,866 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $11,982 | $6,769 | $19,391 | $5,000 |
Gross Profit | 11,982 | 3,287 | 19,391 | 5,000 |
EBITDA | -23,502 | -40,532 | -30,795 | -43,795 |
EBIT | -23,969 | -41,144 | -31,576 | -44,353 |
Net Income | -25,114 | -41,871 | -31,907 | -45,347 |
Net Change In Cash | 11,982 | 6,769 | 19,391 | 5,000 |
Free Cash Flow | -19,567 | -41,014 | 3,456 | -29,411 |
Cash | 35,015 | 44,231 | 100,333 | 90,869 |
Basic Shares | 26,834 | 26,732 | 25,924 | 19,758 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.27 |
2025-06-30 | -$0.32 |
2025-03-31 | -$0.11 |
